As promised, so delivered! Last week we published our very first weekly round-up of news and stories from all around the world concerning diabetes and everything associated with it. Here are this week’s top stories from the world of diabetes.
- FDA Approves New Diabetes Combo LixiLan and IDegLira for T2 Diabetes
Novo Nordisk, the world’s leading diabetes organisation, is in news again. The Food and Drug Administration of USA has given approval to Novo Nordisk’s Xultophy and Sanofi’s Soliqua (known as LixiLan and IDegLira during clinical trials). These two products contain fixed doses of glucagonlike-peptide 1 (GLP-1) receptor agonists and long-acting insulin, from Sanofi and Novo Nordisk respectively and can be used for the treatment of adults with type 2 diabetes. Another good thing about both the drugs is the belief both products will prevent the weight gain that comes from the use of just insulin alone.
- Research Suggests Vitamin D May Prevent Diabetes And Heart Disease
Who could have ever thought that sitting in the sun could be a factor in preventing the onset of diabetes and heart diabetes? A new research carried out by Cedars-Sinai Medical Center in the US suggest that Vitamin D supplements may help restore good bacteria in the gut and help prevent metabolic syndrome, a group of symptoms that are risk factors for diabetes and heart disease.
Suggestion to the readers: Go out; spend some time in the sun!
- New Bluetooth Enabled Insulin Dose Device Helps Users Keep Track Of Their Injections
Keeping track of your insulin dosage and injections is quite a task in itself – a small error can cause great inconvenience. But when technology meets healthcare, good things happen all the time. Insulog, a new Bluetooth enabled insulin dose tracker, can be fitted onto most existing insulin pens to prevent dose errors in people with type 1 diabetes and insulin-treated type 2 diabetes. Insulog has a battery that lasts between five and six days and can be used with different disposable insulin pens, including Flexpen, Solostar, Kwikpen and the FlexTouch pen.
- Dispute between Andhra Pradesh and Telangana On Diabetes Test Meter
Doctors and researchers from Andhra Pradesh and Telangana are split on diabetes test meter. They are in dispute over the cut-off mark for the HbA1c test. So if you are a Rayalaseema native, you are declared diabetic, if your glycated blood reading (HbA1c) is above 6.3. But if you happen to live in Hyderabad or Telangana, you need not worry about being diabetic until your reading crosses 6.5. The globally accepted standard cut-off limit for blood sugar average over a period of eight weeks is 6.5.
- Medtronic and Fitbit Team Up for New GCM mobile app:
Medtronic has joined hands with fitness wearable brand Fitbit to roll out the next version of its continuous glucose monitoring (CGM) iPro2’s myLog mobile app. The app will now include new fitness tracking features. The idea behind this is that integrating a steady stream of data from wearable fitness devices into CGMs could provide users with unique insights into how exercise impacts their blood sugar levels.
- Good news For Type 2 Diabetics: Exercise Can Deter Memory Loss In Type 2 Diabetics
In a study carried out by researchers from University of Tsukaba in Japan, a link was found between moderate aerobic exercise and improving memory loss in people with diabetes.
Stay tuned for more news next week! Also, leave a comment if you think we missed some noteworthy news.